AnaptysBio Inc Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 30.33. In total, the insiders bought 1 550 299 and sold 619 358 ANAB shares in the last 100 trades.

Insider Power

(Last 100 transactions)
30.33
Buy 1 550 299 Shares
Sell 619 358 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 21, 2024 Common Stock Sell Fenton Dennis M 1 950
Jun 18, 2024 Common Stock Sell Renton Hollings 1 950
Jun 15, 2024 Common Stock Buy Fenton Dennis M 3 900
Jun 15, 2024 Restricted Stock Unit Sell Fenton Dennis M 3 900
Jun 15, 2024 Common Stock Buy Marquet Magda 3 900
Jun 15, 2024 Restricted Stock Unit Sell Marquet Magda 3 900
Jun 15, 2024 Common Stock Buy Schmid John P. 3 900
Jun 15, 2024 Restricted Stock Unit Sell Schmid John P. 3 900
Jun 15, 2024 Common Stock Buy Ware J. Anthony 3 900
Jun 15, 2024 Restricted Stock Unit Sell Ware J. Anthony 3 900
Jun 15, 2024 Common Stock Buy Orwin John A 2 035
Jun 15, 2024 Restricted Stock Unit Sell Orwin John A 2 035
Jun 15, 2024 Common Stock Buy Renton Hollings 3 900
Jun 15, 2024 Restricted Stock Unit Sell Renton Hollings 3 900
Jun 15, 2024 Common Stock Buy Jain Rita 4 534
Jun 15, 2024 Restricted Stock Unit Sell Jain Rita 1 300
May 22, 2024 Common Stock Sell Mulroy Dennis 1 500
Mar 26, 2024 Common Stock Sell Faga Daniel 347 441
Mar 25, 2024 Common Stock Sell Faga Daniel 3 000
Mar 22, 2024 Common Stock Sell Faga Daniel 145 940
Feb 16, 2024 Employee Stock Option (right to buy) Sell Loumeau Eric J 5 000
Feb 16, 2024 Common Stock Buy Loumeau Eric J 5 000
Feb 16, 2024 Common Stock Sell Loumeau Eric J 5 000
Jan 30, 2024 Common Stock Sell Mulroy Dennis 3 065
Jan 08, 2024 Common Stock Sell Lizzul Paul F. 2 554
Click to get the best stock tips daily for free!

About AnaptysBio Inc

AnaptysBio AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress... ANAB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT